Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022)
Xeris Biopharma Holdings (XERS) reported Exchange Rate Effect of $1000.0 for Q3 2022, up 150.0% on a YoY basis from $400.0 in Q3 2021, and up 200.0% quarter-over-quarter from -$1000.0 in Q1 2022.
Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022) Analysis & Trends
Xeris Biopharma Holdings has reported Exchange Rate Effect for 3 years, with the latest figure at $1000.0 in Q3 2022.
- For the quarter ending Q3 2022, Exchange Rate Effect rose 150.0% year-over-year to $1000.0; the trailing twelve-month figure through Jun 2023 stood at $1000.0 (up 120.0% YoY), and the FY2021 full-year result was -$3000.0, up 86.36% from the prior year.
- Exchange Rate Effect for Q3 2022 stood at $1000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $6000.0 in Q4 2020, with the low at -$2000.0 in Q3 2021.
- Historically, Exchange Rate Effect has averaged $500.0 across 3 years, with a median of $0.0 in 2021.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect tumbled 133.33% — and 2022, when it soared 150.0%.
- Xeris Biopharma Holdings' Exchange Rate Effect stood at $6000.0 in 2020, then sank by 133.33% to -$2000.0 in 2021, then soared by 150.0% to $1000.0 in 2022.
- The last three Exchange Rate Effect figures came in at $1000.0 (Q3 2022), -$1000.0 (Q1 2022), and -$2000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Xeris Biopharma Holdings | 1.07 Bn | 954.87 Mn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |